INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 9 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 789.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $94,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,500 | $187,000 | 0.00% |
| SIMPLEX TRADING, LLC | 142,300 | $2,315,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 136,300 | $2,218,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |